Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Cell Communication and Signaling : CCS|September 9, 2010
Tumor interactions with soluble factors and the nervous systemMelanie J Voss, Frank Entschladen
Nature Reviews. Clinical Oncology|August 3, 2011
Targeted therapies: Using β-blockers to inhibit breast cancer progressionDesmond G Powe, Frank Entschladen
Cell Cycle (Georgetown, Tex.)|March 25, 2011
Heterotrimeric G protein signaling in cancer cells with regard to metastasis formationFrank Entschladen, Kurt S Zänker, Desmond G Powe
Current Pharmaceutical Design|June 6, 2012
Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugsTheodore L Drell, Kurt S Zanker, Frank Entschladen
Cells|January 16, 2016
Re-Use of Established Drugs for Anti-Metastatic IndicationsFrank Entschladen, Dane A Thyssen, David W Drell
Cancer Immunology, Immunotherapy : CII|March 23, 2004
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytesJan Joseph, Bernd Niggemann, Kurt S Zaenker, et al.
Journal of Periodontology|September 3, 2009
Influence of enamel matrix derivative on primary CD4+ T-helper lymphocyte migration, CD25 activation, and apoptosisGeorg Gassmann, Bettina Schwenk, Frank Entschladen, et al.
International Journal of Cancer|July 13, 2002
Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loopKerstin Lang, Bernd Niggemann, Kurt S Zanker, et al.
Cancer Research|November 20, 2002
The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cellsJan Joseph, Bernd Niggemann, Kurt S Zaenker, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2006
Tumor immune escape mechanisms: impact of the neuroendocrine systemKerstin Lang, Frank Entschladen, Corinna Weidt, et al.
Pageof 10